The study of melanoma lesions in patients with metastatic tumors identified NKp44 ligands in all melanoma samples analyzed and NKp30 ligands in the majority of samples, whereas the expression of NKp46 ligands was null (44). The gene discussed is NCR2; the disease is melanoma.